869090-08-4

Basic information

• Product Name: Benzenamine, N-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
• CAS NO: 869090-08-4
• Molecular Formula: C13H20BNO2
• Molecular Weight: 233.118
• Mol File: 869090-08-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzenamine, N-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, N-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(869090-08-4)
• EPA Substance Registry System: Benzenamine, N-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-(869090-08-4)

Safety Data

• Hazardous Substances Data: 869090-08-4(Hazardous Substances Data)

Upstream product

• 66584-32-5 3-bromo-N-methylaniline 
• 73183-34-3 bis(pinacol)diborane 
• 25216-74-4 tert-butyl (3-bromophenyl)carbamate 
• 591-19-5 m-Bromoaniline 
• 57598-34-2 3-Bromo-N-tert-butoxycarbonyl-N-methylaniline 

Downstream Products

• 1160685-57-3 N-({6-hydroxy-2-[3-(methylamino)phenyl]-5-quinoxalinyl}carbonyl)glycine 
• 1443236-90-5 ethyl 4-(3-(N-methylacrylamido)phenyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate 
• 1443237-57-7 ethyl 4-(3-(methylamino)phenyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate 
• 869090-19-7 methyl (S)-2-benzyloxy-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]propanoate 

Relevant articles and documents

CYANO-SUBSTITUTED INDOLE COMPOUNDS AND USES THEREOF AS LSD1 INHIBITORS

A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1) - mediated diseases or disorders: (I) wherein R1, R2, R3, R4, R5, and R6 are as defined herein.

NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS

Novel biaromatic compounds that modulate peroxisome proliferator-activator receptors, known as PPAR, having the formula (I): are formulated into pharmaceutical compositions useful in human or veterinary medicine, or alternatively, in cosmetic compositions.

NOVEL BIAROMATIC COMPOUNDS WHICH ACTIVATE PPARγ-TYPE RECEPTORS, THEIR PROCESS OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS

The invention relates to novel biaromatic compounds which correspond to the following general formula (I) and to their method of preparation and to their use in pharmaceutical compositions intended for use in human or veterinary medicine, in particular in